Experimental Drug Earns Orphan Drug Designation for Polymyositis and Dermatomyositis
source: pixabay.com

Experimental Drug Earns Orphan Drug Designation for Polymyositis and Dermatomyositis

According to a story from Biotech 365, the biotechology company Kezar Life Sciences, Inc. recently announced that its experimental therapy KZR-616 has earned Orphan Drug designations from the US Food…

Continue Reading Experimental Drug Earns Orphan Drug Designation for Polymyositis and Dermatomyositis
Safe Pregnancies with Rheumatic Diseases are Possible with Planning
source: pixabay.com

Safe Pregnancies with Rheumatic Diseases are Possible with Planning

Dr. Lisa Sammaritano from Weill Cornell Medical College has explained a way to lower risks within pregnancy for those with rheumatic diseases. Pregnancy and Rheumatic Diseases Patients who have a…

Continue Reading Safe Pregnancies with Rheumatic Diseases are Possible with Planning
Researchers Find Effective Biomarker for Predicting Severity of Myositis-Associated Interstitial Lung Disease
source: pixabay.com

Researchers Find Effective Biomarker for Predicting Severity of Myositis-Associated Interstitial Lung Disease

A team of researchers recently evaluated a new biomarker in interstitial lung disease to see whether or not it could predict disease severity and ultimately mortality. The Biomarker Surfactant protein…

Continue Reading Researchers Find Effective Biomarker for Predicting Severity of Myositis-Associated Interstitial Lung Disease
Researchers Discover Causes of Graft-Verus-Host-Disease
Source: Pixabay

Researchers Discover Causes of Graft-Verus-Host-Disease

Research into graft-versus-host-disease (GVHD), a condition that can occur after bone marrow transplants, has yielded promising results. A study, reported by BrightSurf, found that a particular group of microRNA molecules involved…

Continue Reading Researchers Discover Causes of Graft-Verus-Host-Disease